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Abstract  
Rhomboids, proteases containing an unusual membrane-integral serine 
protease active site, were first identified in Drosophila, where they fulfill an 
essential role in epidermal growth factor receptor signaling, by cleaving 
membrane-tethered growth factor precursors. It has recently become 
apparent that eukaryotic genomes harbor conserved catalytically inactive 
rhomboid protease homologs, including derlins and iRhoms. Here we highlight 
how loss of proteolytic activity was followed in evolution by impressive 
functional diversification, enabling these pseudoproteases to fulfill crucial 
roles within the secretory pathway, including protein degradation, trafficking 
regulation, and inflammatory signaling. We distil the current understanding of 
the roles of rhomboid pseudoproteases in development and disease. Finally, 
we address mechanistically how versatile features of proteolytically active 
rhomboids have been elaborated to serve the sophisticated functions of their 
pseudoprotease cousins. By comparing functional and structural clues, we 
divine common principles shared by the rhomboid superfamily, and make 
mechanistic predictions.  
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containing protein 2. 
  
 4 
1. Introduction  
Rhomboid proteases are conserved group of polytopic membrane proteins 
that cleave substrates within the plane of cellular membranes. First described 
in Drosophila melanogaster, Rhomboid-1 is a key activator of the epidermal 
growth factor receptor (EGFR) by cleaving its activating ligands within their 
transmembrane (TM) anchor, triggering their secretion, enabling signaling to 
neighboring cells [1]. Rhomboids actually fulfill diverse functions in all 
kingdoms of life, including: pro-peptide removal of the Providencia stuartii 
TatA protein translocase, host cell invasion by apicomplexan parasites, and 
protein degradation along the endoplasmic reticulum (ER)-associated 
degradation (ERAD) pathway [2, 3]. The rhomboid active site is located within 
a conserved six-pass TM domain core (the ‘rhomboid domain’, Fig. 1). Some 
rhomboid homologs include additional TM segments and extended tails 
harboring diverse functional domains, fused either to the amino- or carboxy-
terminus (Fig. 1) [4]. The crystal structures of the Escherichia coli rhomboid 
protease GlpG, solved to atomic resolution, revealed a serine-histidine dyad 
active site located, several ångstroms beneath the membrane surface, in the 
center of a six TM helix-bundle [5]. Other conserved features include the 
tryptophan-arginine (WR) motif, of important but unknown function, that 
contributes to the prominent L1 loop extending sideways into the upper leaflet 
of the lipid bilayer (Fig. 1).  
 In eukaryotes, several tightly clustered linages of rhomboid 
homologues that lack key catalytic residues were identified, and are predicted 
to be proteolytically inactive [4, 6]. As we highlight below, the functions of 
these rhomboid pseudoproteases are as diverse and fundamental as their 
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active relatives. Our synthesis reveals principles concerning how rhomboid 
pseudoproteases functionally interact with protein clients in the membrane 
environment, and mechanistically how they relate to their active counterparts. 
For clarity, we define the ‘rhomboid superfamily’ as the universe of rhomboid 
homologues containing the six-TM rhomboid fold [5], and operationally 
subdivide these into ‘rhomboid proteases’ versus ‘rhomboid 
pseudoproteases’.  
 
2. Mysterious inactive protease homologues  
Extensive sequence comparisons indicated that rhomboid proteases share 
certain features with the ERAD factor derlin [7]. Moreover, automated gene 
annotation by hidden Markov models, and BLAST searches, identified several 
more distantly related catalytically inactive rhomboid relatives amongst the 
entire eukaryotic kingdom including, fungi, plants and red algae [4, 6, 8-10]. 
Crucially, most genes encoding these mysterious ‘dead’ rhomboids are well 
conserved, indicating that they are not random mutants or pseudogenes [3, 
11]. Indeed, all rhomboid pseudoproteases are expressed widely, supporting 
the notion that they have genuine and universal functions. We may reason, 
that these diverse set of pseudoenzymes evolved via several independent 
gene duplication events of different rhomboid proteases, followed by 
diversification, and loss of proteolytic activity [12]. The easiest way to 
envisage loss of proteolytic activity during evolution involves loss of the 
catalytic serine or histidine. However, certain iRhoms contain an intact 
catalytic dyad, but have acquired a conserved proline in the x-position of the 
‘GxSG’ rhomboid protease active site consensus motif. This destroys the 
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active site geometry, making them inactive (Fig. 1) [4, 13]. Common amongst 
membrane protein families, a low sequence consensus between different 
lineages poses the question of whether all rhomboid homologues form a 
superfamily, or whether distinct groups better represent them. Since currently 
structural similarity cannot be demonstrated experimentally, the best evidence 
for a shared fold is the apparent conservation of the six-TM rhomboid domain, 
containing conserved key ‘anchor’ residues such as an Engelmann di-glycine 
helix-helix interaction motif (GxxxG) in TM segment 6 (Fig. 1). Homology 
modeling based on the E. coli GlpG rhomboid protease structure indicates 
that human Derlin1 and the Schizosaccharomyces pombe Dsc2 rhomboid 
pseudoprotease (see below) indeed form a rhomboid fold, with the 
characteristic L1 loop clamping a six-helix bundle [6, 14].  
 Overall, there is growing evidence that the diverse set of rhomboid 
homologues can be seen as a superfamily, implying potentially strong 
structural and functional parallels and potentially a shared mechanism in 
recognition of substrates and pseudosubstrates. However, this remains 
speculative until high-resolution structures of rhomboid pseudoproteases 
become available. 
 
3. Trafficking control  
The rhomboid pseudoproteases comprise iRhoms, derlins and UBAC2, which 
localize to the ER; and RHBDD2, RHBDD3 and TMEM115, which localize to 
the Golgi apparatus and endosomes, respectively [3, 6, 11, 15-18]. As 
discussed below, an emerging theme is trafficking control, whereby the 
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interaction between a rhomboid pseudoprotease and its client enables a 
triage decision, trafficking, degradation, or compartmental signaling. 
 
3.1 Pseudoprotease function in growth factor signaling and inflammation  
iRhoms are metazoan-specific rhomboid pseudoproteases that differ from 
their catalytically active counterparts in several respects [3, 4, 11]. First, the 
‘vestigial’ catalytic site of iRhoms follows the ‘GPxx’ consensus, described 
above. Second, iRhoms contain an extended cytoplasmic amino-terminus that 
fulfills a regulatory role (see below). Third, iRhoms have a unique structure 
called the ‘iRhom homology domain’, a cysteine-rich globular domain, inserted 
within the L1 loop (Fig. 1) [4]. 
 We will now contemplate how iRhoms relate to rhomboid proteases, 
using Drosophila iRhom as a reference point. Fly iRhom localizes to the ER 
and is expressed in the nervous system and brain [13]. iRhom deficient flies 
develop normally, but exhibit a pronounced defect in daytime activity. As 
mentioned above, rhomboid proteases control EGFR signaling in Drosophila. 
Specifically in the central nervous system, it modulates wakefulness. 
Interestingly, iRhom knockout (KO) flies exhibit a phenotype similar to that 
caused by overexpression of active rhomboids in the central nervous system 
[13]. Although the molecular mechanism remains to be defined, Drosophila 
iRhom fulfills a triage role by binding to EGFR ligands and passing them over 
to the ERAD machinery thereby limiting their availability to active rhomboids 
[13]. Hence, in the case of Drosophila iRhom, pseudoprotease function 
counteracts the role of active rhomboids, a common principle in 
pseudoprotease biology [11].  
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 The functional relationship between active rhomboids and iRhoms is 
harder to decipher in mammals. The role of rhomboid proteases in the control 
of EGFR signaling is limited in mammals; instead, the metalloprotease 
ADAM17 (for ‘a disintegrin and metalloproteinase 17’, also known as ‘TNF-
converting enzyme’, TACE) cleaves multiple mammalian EGFR ligands, 
fulfilling an analogous role to Drosophila rhomboid [19]. However, in an 
evolutionary twist, mammalian iRhoms fulfill an indirect but essential role in 
EGFR ligand release [12, 20-22]. Mammalian iRhoms act as trafficking factors 
that escort ADAM17 from the ER to the later secretory pathway (Fig. 2A). 
iRhom mutant cells are defective in trafficking of ADAM17, resulting in the 
retention and inactivation of ADAM17 in the ER [12, 20-22]. 
 Mammalian genomes contain two iRhoms that fulfill redundant, but 
also, specialized, roles in ADAM17 activation. As well as being the sheddase 
for EGFR ligands, ADAM17 has numerous substrates, including the 
inflammatory cytokine, TNF (tumor necrosis factor) [23]. Similar to ADAM17 
KO mice, mice deficient for iRhom2 are defective in TNF release from myeloid 
cells. iRhom2 KO mice respond less severely to sepsis, are protected from 
experimental arthritis, but exhibit increased sensitivity to Listeria infection, 
hallmarks of TNF biology [12, 22-24]. iRhom redundancy is illustrated by the 
fact that iRhom single KO mouse embryonic fibroblasts retain substantial 
ADAM17 activity, whereas ADAM17 is inactive in double knockout (DKO) 
cells [20, 21]. The phenotype of iRhom1 KO mice and iRhom1/2 DKO mice 
themselves is controversial: a recent study reported that iRhom1 mice are 
aphenotypic [20], whereas a previous report found that iRhom1 KOs mice 
exhibited a cachectic phenotype, defects in several professional secretory 
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tissues, and brain hemorrhages [21]. Concerning iRhom DKO mice, one study 
found that DKO embryos were lethal, whereas the later study reported 
perinatal lethality, similar to ADAM17 KO mice [20, 21, 25].  
 In addition to its importance in leukocytes, iRhom2 is required for 
ADAM17 activity in microglia and potentially in the liver [20]. Likewise, iRhom1 
is expressed highly in many regions of the brain [20] potentially explaining the 
brain hemorrhages observed in ADAM17 KO mice and in one iRhom1 KO 
study [21, 26].  
 The implication of the rhomboid superfamily in innate immunity is not 
restricted to iRhom2. Mice deficient for the rhomboid pseudoprotease 
RHBDD3, exhibit spontaneous autoimmune disease, driven by defects in T 
cell homeostasis caused by hyperactivation of the inflammatory transcription 
factor NFB, in dendritic cells [18]. Rather than a trafficking role, RHBDD3 
localizes to endosomes, acting as a scaffold for ubiquitin-dependent 
recruitment of the NFB pathway kinase IKK to the deubiquitinating enzyme 
A20, enabling the latter to blunt IKK-driven NFB responses [18] (Fig. 2B). 
 
3.2 Association of iRhoms and RHBDD2 with disease  
In spite of the implication of rhomboid pseudoproteases in processes 
connected to inflammation, autoimmunity and cancer, with the exception of 
iRhoms, evidence for an association with disease is currently lacking. As 
deregulated autocrine EGFR signaling drives tumors [19], it is interesting to 
note that iRhom2 mutations are causal for an autosomal dominant disease 
called Tylosis with esophageal cancer [27]. In several families, iRhom2 
mutations [27] cluster within a conserved hotspot in the iRhom N-terminus. 
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Tylosis is characterized by keratinocyte hyperproliferation and affected 
patients develop oesophageal cancer in later life [27]. A potential explanation 
for this phenotype is that the iRhom2 mutants are gain of function mutants, 
thereby enhancing their ability to activate ADAM17, which subsequently 
increases release of EGFR ligands, a key proliferation and differentiation 
signal for keratinocytes. Consistent with this, tylotic keratinocytes display 
increased EGFR ligand secretion and have increased migratory and 
proliferative potential [28]. 
 Finally, a point mutation in a region close to the cytoplasmic loop 
between TM helices 2 and 3 of another rhomboid pseudoprotease, RHBDD2 
[16], has been identified in a familial form of retinitis pigmentosa, a disease 
causing progressive vision loss. Whether the disease is caused by a loss of 
functional RHBDD2 (which is expressed in mouse photoreceptors [16]), or is a 
secondary consequence of ER stress caused by ER retention of misfolded 
RHBDD2, remains to be ascertained. 
 
3.3. Mechanistic roles of iRhoms  
We will now discuss the mechanism whereby mammalian iRhoms control 
ADAM17 trafficking. Notably ADAM17 binds to iRhom2, implying that its effect 
may be direct [12]. iRhom could modulate ADAM17 biogenesis in the ER, 
cargo recognition, or its trafficking through the secretory pathway. However, 
as ER exit is contingent on protein folding, it is not trivial to separate these 
roles. Sidestepping this, notably, purified ADAM17 from iRhom KO extracts 
can be activated by incubation with the pro-protein convertase responsible for 
ADAM17 maturation in the trans-Golgi (Fig. 2A) [12]. This argues that 
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ADAM17 folding largely proceeds normally, invoking the other mechanisms 
discussed above.  
  Another way to address function is to reflect upon the subcellular 
localization of iRhom, but this too is controversial: endogenous iRhom2 in 
primary macrophages has EndoH-insensitive glycans, suggesting that can 
traffic at least to the medial-Golgi [12]. On the other hand, overexpressed 
iRhom localizes variously to the ER, Golgi, and a fraction is found at the cell 
surface [13, 28, 29]. These observations provoke the question of whether 
iRhom associates with ADAM17 throughout its journey to the cell surface. 
Speculatively, the corollary of this is that ADAM17-iRhom complexes could 
exist for purposes beyond trafficking, such as an allosteric regulator, or 
substrate recruitment platform. 
 The identification of gain-of-function mutations in the iRhom N-terminus 
implies an important regulatory role for the cytoplasmic tail. This is interesting 
because membrane protein tails, including iRhom, contain sorting motifs that 
determine ER exit or retrieval. Hence, cofactor binding to the iRhom tail could 
govern its ER exit, and signals that impinge on ADAM17 trafficking [30] may 
control ER exit of iRhom. Notably, N-terminally truncated versions of iRhom 
promote ADAM17 activity more efficiently, as do the tylotic mutants discussed 
above [28], suggesting that the iRhom tail contains an autoinhibitory moiety. 
The structural basis for this, and how the putative de-repression is achieved, 
are unclear. 
 Given that some iRhom1 KO phenotypes are not explicable purely by 
ADAM17 biology [21] this could imply that additional iRhom clients exist. 
Notably, a genome wide screen identified iRhom1 as a stimulator of 
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proteasome activity [31] and iRhom1 has been implicated in regulation of the 
hypoxic transcription factor Hif1 [32]. Notably, mice null for Hif1 exhibit 
vascular defects, as do ADAM17 KO mice [26]. 
 
3.4. Emerging role of TMEM115 in retrograde trafficking  
Continuing the theme of trafficking control, we turn to TMEM115, a Golgi-
localized rhomboid pseudoprotease [17]. TMEM115 knockdown cells exhibit a 
delay in experimentally-induced Golgi fragmentation, implicating TMEM115 in 
retrograde transport of COPI vesicles from the cis-Golgi to the ER [17]. This is 
significant because the retrograde machinery is crucial to maintain 
homeostasis of the secretory pathway, returning escaped ER-resident 
proteins from the cis-Golgi [33]. COPI vesicles also ensure spatial fidelity of 
Golgi-resident proteins, against a flux of anterograde movement [34].  
 The COG (conserved oligomeric Golgi) complex facilitates COPI 
vesicle tethering [35]. Notably, the cytoplasmic tail of TMEM115 interacts both 
with COPI vesicles, and the COG complex [17]. Similar to COG mutant cells, 
TMEM115 knockdown cells exhibit defects in O-glycosylation, consistent with 
mislocalization of glycosylation enzymes caused by defective retrieval 
mechanisms [17]. This implies an important general role for TMEM115 in 
retrograde trafficking, as a scaffold interconnecting COPI vesicles with other 
tethering components [35]. 
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4. Role in quality control and protein dislocation  
4.1. Der1 defines a versatile safeguard of ER protein homeostasis  
As the portal to the secretory pathway, the ER harbors a sophisticated quality 
control machinery that targets misfolded proteins and surplus protein subunits 
into ERAD (for recent reviews see [36, 37]). In a slightly modified manner, 
regulatory ERAD (ERAD-R) tunes the flux of natively-folded proteins by 
targeting them for degradation [37]. Similarly, certain viruses use the ERAD 
machinery to down regulate host cell factors such as to escape the immune 
response [38].  
 The first molecular insights into ERAD were obtained by a genetic 
screen in Saccharomyces cerevisiae that identified Der1 (for ‘degradation in 
the ER 1’) as the first component of the ERAD machinery [39]. Yeast Der1 is 
the founding member of a family called derlins, which as discussed below 
were recently recognized to be rhomboid pseudoproteases. Subsequently, 
genetic and functional studies revealed that Der1 interacts with ERAD 
scaffolding proteins including Usa1 (known as Herp1 in mammals), thereby 
eventually targeting ERAD substrates, via an unknown mechanism, for 
ubiquitination by the E3 ubiquitin ligase Hrd1 (Fig. 3A) [40-43]. Downstream of 
this reaction, a number of other factors mediate transit of ERAD substrates to 
the proteasome for final destruction [36]. The hexameric AAA+-type ATPase 
Cdc48 (known as p97 or VCP in mammals), and associated ubiquitin-binding 
proteins, are thought to provide the major driving force and directionality of 
these processes [37, 44]. In a related manner, the second yeast derlin protein 
Dfm1 (for ‘Der1-like family member 1’) is a key component of several ERAD 
complexes, functionally interacting with either Hrd1, the second yeast ERAD 
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E3 ubiquitin ligase Doa10 [45], or with the aspartyl intramembrane protease 
Ypf1 [37, 46]. Interestingly, whereas Der1 is required for turnover of soluble 
ERAD substrates but is not essential for degradation of TM proteins [39, 43, 
47, 48], the few known Dfm1 clients are all membrane proteins [45, 46]. This 
indicates that the two yeast derlins define alternative branches of the ERAD 
pathway specific for distinct protein classes. However, in yeast not all ERAD 
substrates depend on Der1 or Dfm1 [43, 45, 49], suggesting that redundant 
degradation routes exist.  
 
4.2. What has identification of derlins as rhomboid pseudoproteases taught us 
about mechanism?  
Der1-like proteins are in fact conserved and play key roles in ER proteostasis 
in mammals. The first human Der1 homologue, referred to as Derlin1 (to 
indicate that it is Der1-like), was identified by probing for factors involved in 
degradation of MHC class I heavy chains by human cytomegalovirus [50, 51]. 
Despite clear evidence that derlins interact with aberrant polypeptides, 
directing them from the ER lumen, or the plane of the ER membrane, towards 
ubiquitylation and extraction [52-56], the exact molecular mechanism of 
dislocation is still debated. Whereas initially yeast Der1 was suggested to act 
as a receptor for ERAD substrates [39], subsequently human Derlin1 was 
hypothesized to form a protein-conducting dislocation channel [50, 51].  
 Our perspective on derlin mechanism recently became illuminated 
when, building upon previous observations [7], the Kopito lab noted that 
derlins are rhomboid pseudoproteases, providing a homology model for 
Derlin1 based on the E. coli rhomboid GlpG structure [6]. One important 
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consequence is that the architecture of human Derlin1 is now recognized to 
conform to the six TM rhomboid domain [6], rather than the 4 TM architecture 
previously assumed for mammalian and yeast derlins. In fact, confusion of 
topological architecture has hampered mechanistic studies on many rhomboid 
pseudoproteases [16, 17, 47, 52]; further biochemical and structural studies 
are required to resolve this discrepancy. Another important implication of the 
derlin-rhomboid interrelationship is that the protein-conducting channel 
hypothesis (mentioned above) becomes implausible. Although it is not entirely 
clear how rhomboid proteases interact with their substrates [57, 58], the 
rhomboid fold adopts a compact structure, undermining the likelihood that 
derlins form an aqueous ERAD membranous pore. 
 Importantly, the recognition of a common ancestry between rhomboids 
and derlins helps to rationalize several previous observations. Mutation of 
what are now recognized to be shared features, namely the ‘WR’ motif in the 
L1 loop and the ‘GxxxG’ helix dimerization motif in TM segment 6 (Fig. 1), 
block both, protease and pseudoprotease function [6, 7, 59, 60]. Likewise, the 
serine-59-leucine loss-of-function mutation encoded by the yeast der1-2 allele 
found in the original genetic screen [39, 47], affects a conserved residue that 
derlins share with most rhomboid proteases [7]. These striking similarities in 
the L1 loop strengthen the hypothesis of structural conservation between 
secretory pathway rhomboids and derlins. This is important since it potentially 
indicates a shared mechanism for substrate/client recognition. Further 
supporting this hypothesis, the ER-resident rhomboid protease RHBDL4 
combines features from both sides: ubiquitin-dependent recognition of ERAD 
substrates, and intramembrane protease activity (Fig. 3B) [61]. Intriguingly, 
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RHBDL4 is unique amongst rhomboid proteases in that it cleaves most of its 
substrates at various alternative positions, ranging from the TM region to 
luminal loops and ectodomains [61]. This is consistent with cleavage by 
RHBDL4 of ERAD substrates at different stages in the retrotranslocation 
journey through the membrane, and demonstrates a mechanistic collaboration 
between RHBDL4 and dislocation. It remains to be investigated whether this 
proteolytic feature is shared with other rhomboid proteases, or whether it 
represents a unique adaptation in RHBDL4 – a nexus between rhomboid 
proteolysis and ERAD. 
 
4.3. Physiolgoical and pathological roles of mammalian derlins  
Whereas in yeast the ERAD pathway is mainly centered around two E3 
ligases, mammals have an expanded set of E3s that form a complex protein 
network in concert with a wide range of ER quality control and ERAD factors 
[62]. This presumably allows flexible adaptation to the individual properties of 
misfolded proteins, to cope with proteostatic demands imposed by larger 
genomes, multicellularity, and longer life spans [36, 37]. This increased 
complexity is also reflected in three mammalian Der1 orthologs [62, 63]. 
Derlin1 and Derlin2 are expressed ubiquitously, whereas Derlin3 is restricted 
to the placenta, pancreas, spleen, and small intestine [63].  
 Given their importance in safeguarding the ER from misfolded proteins, 
this predicts that derlin KO mice should phenotypically resemble mutants in 
key sensors of the unfolded protein response, such as Ire1, PERK or ATF6 
[64]. Hence, one would expect to observe defects in professional secretory 
cells and tissues including plasma cells, the pancreas, liver, and the secretory 
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cells of the intestinal epithelium [65-68]. Unfortunately, consistent with their 
ubiquitous expression pattern, knockout of Derlin1 [69] and Derlin2 [70] in 
mice results in early embryonic versus perinatal lethality, respectively, 
precluding discerning many of these anticipated phenotypes. In contrast, 
Derlin3 deficient mice appear normal [69]. Nonetheless, tissues from Derlin2 
KO mice exhibit constitutive ER stress responses [70], highlighting Derlin2’s 
physiological importance for ERAD. However, with the exception of skeletal 
abnormalities caused by secretory defects in chondrocytes, most professional 
secretory tissues are in fact normal in Derlin2 KOs [70]. Future work exploiting 
conditional Derlin1 mutant and Derlin1/2 double knockout mice will reveal 
their putative roles in ER homeostasis-associated diseases, viral infection, 
and other processes requiring retrotranslocation, such as antigen cross-
presentation [71].   
 Concerning the association between derlins with cancer, although 
there is no causal link, conceptually, upregulation of ERAD may be important 
to fulfill proteostasis demands in cancer cells, which have elevated 
translational rates, and suffer hypoxic conditions, conducive to protein 
misfolding. Some evidence in favor of this comes from a study showing that 
tumor lines positive for the oncogene HER2 upregulate the ERAD machinery 
[72]. Crucially, cells unresponsive to HER2-targeting drugs are sensitive to 
ERAD inhibition, displaying the ERAD ‘addiction’ alluded to above. However, 
the opposite of this has been observed for Derlin3, whose expression is 
silenced in some colorectal cancer lines [73]. In fact, Derlin3 promotes ERAD 
of the glucose transporter Glut1. Tumor-associated epigenetic silencing of 
Derlin3 hence elevates Glut1 levels, allowing a shift in tumor cell metabolism, 
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from oxidative phosphorylation to glycolysis – a characteristic of cancer [73]. 
There is clearly much more to be learned concerning how derlins impacts on 
development, homeostasis and disease, but these examples illustrate their 
potential importance for proteostasis control. For similar reasons, although 
causal evidence is still lacking, one can envisage the implication of derlins in 
protein folding diseases of the secretory pathway, included inflammatory 
bowel disease and type II diabetes [74]. 
 Although there are differences in the mouse KO phenotypes of 
individual derlins, it is not yet clear whether the three paralogs have different 
functions at the molecular level. Derlin1, the best characterized, serves a role 
in multiple arms of the ERAD network, dealing with both soluble and 
membrane-anchored substrates. First, Derlin1 serves as a key factor of the 
Hrd1 ERAD complex (Fig. 3A) [62, 75], which is commonly regarded as the 
major ERAD activity. In this canonical dislocation route, multiple quality 
control factors such as Sel1L, which mediates interaction with the luminal 
lectin OS9 and acts as substrate receptor for soluble ERAD substrates [76], or 
BAP31, a protein sorting factor for TM cargo [77], collectively deliver ERAD 
substrates to Derlin1. More recently, an alternative dislocation route centered 
on the E3 ligase TMEM129 has been shown to mediate human 
cytomegalovirus-induced MHC degradation of MHC class I [78, 79]. 
Furthermore, Derlin1 also contributes to non-canonical degradation routes, in 
conjunction with the intramembrane protease SPP (signal peptide peptidase) 
and the E3 ligase TRC8 [59]. When associated with SPP, Derlin1 interacts 
with an ER luminal portion of the type II membrane protein substrate XBP1u, 
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thereby targeting it for SPP-catalyzed cleavage and p97-independent 
degradation [37, 59]. 
 Notably, derlins are also implicated in a so-called ‘pre-emptive’ ER 
quality control pathway. During ER stress, they reroute nascent chains that 
fail translocation and signal peptidase cleavage, from the signal recognition 
particle, to the cytoplasmic Bag6 complex and subsequently, the proteasome 
[80]. This result indicates that derlins provides a general interaction interface 
for aberrant TM proteins. In summary, derlins are versatile proteostasis 
regulators that have evolved multiple ways to interact with topologically 
diverse clients, via a variety of functionally distinct ERAD machineries.  
 
4.4. UBAC2 and Dsc2  
Another rhomboid pseudoprotease that is predicted to bind ubiquitin via a 
conserved cytoplasmic, C-terminal UBA domain is UBAC2 (for ‘ubiquitin-
associated domain-containing protein 2’) (Fig. 1) [6, 62]. While its 
phylogenetic relationship to derlins is unclear, its localization, physical and 
functional interaction with ERAD factors including the E3 ligase gp78, 
implicate it within the ERAD network [6, 62]. In a striking contrast, Dsc2, the 
homologue in the fission yeast S. pombe, Dsc2 localizes to the Golgi 
apparatus and is a component of a stable multi-protein E3 protein ligase 
complex implicated in activation of the SREBP (sterol regulatory element-
binding protein) transcription factors (Sre1 and Sre2), key regulators of lipid 
biogenesis [14, 81]. On the other hand, human UBAC2 serves as an ER 
tether for the p97 adaptor protein UBXD8, controlling its trafficking from the 
ER to lipid droplets. In lipid droplets, UBXD8 represses the activity of adipose 
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triglyceride lipase, the key enzyme involved in triglyceride turnover. This 
implicates UBAC2 in control cellular lipid storage [15], suggesting that UBAC2 
orthologs share a common role in integrating the cellular metabolic state by 
recruiting regulatory factors to polytopic E3 ubiquitin ligases. However, the 
respective metabolic pathways controlled by human versus S. pombe UBAC2 
orthologs appear distinct, and precisely how UBAC2 and Dsc2 interplay with 
their clients remains to be investigated. Notably, UBAC2 has been identified, 
in genome-wide association studies, as a candidate gene for Behçets 
syndrome, a complex inflammatory condition of unknown etiology [82]. It is 
difficult to reconcile this with the cell biological observations mentioned above. 
One tentative possibility is that UBAC2 impacts on lipid droplet homeostasis in 
inflammatory cells, which utilize triacylglyceride as a precursor for the 
production of inflammatory lipid species called eicosanoids [83]. Clearly, the 
precise physiological role of UBAC2 in metabolic control (potentially ERAD-R) 
awaits knockout mouse studies.  
 
4.5. Variation of the theme: Protein import into complex plastids  
Further insights into the function of rhomboid family proteins in recognition of 
proteins at the membrane surface has recently been derived from so-called 
complex plastids of red algae, photosynthetic organisms that are thought have 
evolved via secondary endosymbiosis of two unicellular eukaryotes [84]. In 
the second outermost membrane of up to four distinct membrane layers 
forming these complex organelles, referred to as the periplastidal membrane, 
a symbiont specific ERAD-like machinery (SELMA) exists that specifically 
targets certain proteins from the ER lumen, to further traverse into the plastid 
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interior [9]. Like for higher plants, most plastid proteins are synthesized from 
nuclear genes and must be imported into the plastid. Depending on the sub-
organellar destination, several membranes must be sequentially crossed. 
SELMA clients first have to be co-translationally translocated in a Sec61-
dependant manner across the outermost plastid membrane, which is 
continuous with the canonical ER, and subsequently they are released from 
the ER lumen into the periplasmic compartment. This process topologically 
resembles protein dislocation into the cytoplasm and is mediated by a 480-
kDa multiprotein SELMA complex. The complex consists of several ERAD-like 
components including two symbiont-specific derlins, known as sDer1 and 
sDer2, an E3 ubiquitin ligase, and the rhomboid protease ptsRhom3 [85, 86]. 
Consistent with a role of SELMA in protein translocation, two symbiontic 
copies of the AAA+-ATPase Cdc48 have also been identified [87]. An 
important distinction to ERAD, however, is that for SELMA translocation is 
uncoupled from degradation and the imported proteins either stay in the 
periplasmic compartment, or are further imported into plastid intermembrane 
space. Although like for ERAD, the molecular mechanism of SELMA is just 
beginning to unfold, these striking parallels highlight the unique role of 
rhomboid pseudoproteases and proteases as versatile protein interaction 
interfaces in the plane of the membrane.  
 
5. Conclusions  
Loss of proteolytic activity during evolution has enabled rhomboid 
pseudoproteases to acquire fundamental additional roles within the secretory 
pathway, including protein translocation, vesicle tethering, triage, forward 
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trafficking, and acting as signaling scaffolds (Fig. 2 and 3). Many clues still 
remain to be unveiled. From the organismal perspective, we lack insights into 
the physiological role of UBAC2, RHBDD2 and TMEM115, as well as the 
tissue-specific roles of derlins.  
 A precedent from studies on pseudoenzymes is that they frequently act 
as allosteric regulators of their active counterparts [11]. This example is 
conspicuously absent here; perhaps the discrepancy will be resolved upon 
learning more about the physiological roles of rhomboid proteases 
themselves. Meanwhile, this provokes the question of whether the 
mechanisms of rhomboid pseudoproteases diverge radically from rhomboid 
proteases. iRhoms interact with their TM clients, suggesting that they use a 
vestigial ‘exosite’ for recognition [19, 58]. This feature, harbored within the 
rhomboid core, has been reported for active rhomboids [88, 89] and may 
dependent on dimerization. For fly iRhom, recognition precedes passing a 
client into ERAD, whereas for mammalian iRhoms, it directs the client 
protein’s vesicular trafficking. Notably, iRhoms and rhomboid proteases both 
recognize type I membrane proteins, suggesting broad similarities in the client 
recruitment interface. This contrasts with the ability of derlins and the ERAD 
rhomboid protease RHBDL4 to associate with a topologically heterogeneous 
variety of misfolded proteins, implying an intriguing exosite specialization. 
 Continuing on the theme of conservation of mechanism, we now 
address the L1 loop defined by a characteristic WR motif (Fig. 1), a 
functionally important structure conserved between active rhomboids and 
derlins. Structural data suggests that by supporting the flexible six-TM helix 
bundle it stabilizes the active rhomboid core [90], potentially allowing the 
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coordinated conformational rearrangements necessary for substrate 
recruitment, partial unfolding of the substrate surrounding the scissile peptide 
bond, and the proteolytic cycle. Extrapolating this to derlins predicts that the 
L1 loop stabilizes the rhomboid core to coordinate rearrangements necessary 
for client unfolding, or threading misfolded ERAD substrates through the 
bilayer. By contrast, the L1 loop of iRhoms contains a large insertion, the 
iRhom homology domain (Fig. 1). We await structural and functional studies 
to elucidate the impact that this disrupted L1 loop has on the iRhom core, and 
to establish the structure and role of the iRhom homology domain. Very 
speculatively, this could imply that iRhoms have repurposed the putative L1 
loop ‘unfoldase’ function for something else, perhaps a protein-protein 
interaction surface. The implication that iRhoms may not be able to engage in 
client protein unfolding would place them in a class distinct from derlins and 
rhomboid proteases and frames the role of Drosophila iRhom in the triage 
process described above, rather than directly in ERAD. However, this is 
speculative, and the model also needs to incorporate the ability of symbiont-
specific derlins in the SELMA complex to engage in protein translocation 
without predisposing clients to degradation. Whether SELMA derlins have lost 
‘unfoldase’ function, or can engage in cycles of partial unfolding followed by 
refolding, remains to be addressed. 
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Figure Legends  
Figure 1. Rhomboid family proteins share a membrane-integral core 
domain.  
Topology models for human rhomboid protease RHBDL2 and 
pseudoproteases iRhom2, Derlin1, UBAC2, RHBDD3 and TMEM115. The 
conserved six-pass TM ‘rhomboid domain’ is shown in blue. Structurally 
important features such as the ‘GxxxG’ TM helix-helix dimerization motif and 
the L1 loop are indicated. Additional domains including TM helices, the iRhom 
homology domain (IRHD), the p97/VCP-binding motif (VBM) and ubiquitin 
binding domains (UBA), are highlighted in red. For rhomboid proteases, the 
active site motifs ‘GxSG’ and ‘H’ form a catalytic dyad between TM helices 4 
and 6. iRhoms have a ‘GPxG’ sequence in this position. 
 
Figure 2. Rhomboid pseudoproteases control secretion dynamics.  
Models illustrating the proposed functions of mammalian iRhoms, TMEM115, 
and RHBDD3 in the secretory pathway. (A) Mammalian iRhom2 binds to 
ADAM17, mediating its trafficking from the ER to the Golgi apparatus, wherein 
it is activated by the pro-protein convertase furin (B) RHBDD3 localizes to 
endosomes. During inflammatory signaling, its UBA domain acts as a 
scaffold, bringing the NFB pathway kinase IKK in contact with the 
deubiquitinase A20, attenuating NFB activation. (C) TMEM115 interacts with 
the COG complex, (indicated in green) and with COPI-coated vesicles, 
coordinating retrograde trafficking between the cis-Golgi and the ER.  
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Figure 3. Rhomboid family proteins are involved in ERAD.  
In the canonical ERAD dislocation pathway (A), misfolded proteins are 
recognized by the rhomboid pseudoprotease Derlin1 and substrate receptors 
such as OS9/Sel1L. The ERAD substrate is dislocated across the ER 
membrane through an unknown mechanism, then ubiquitylated by the 
membrane-tethered ubiquitin E3 ligase Hrd1. On the cytoplasmic side, the 
AAA+-ATPase p97 extracts the ubiquitylated substrate from the membrane, 
targeting it for proteasomal degradation. An alternative ERAD route (B) 
involves the rhomboid protease RHBDL4, which binds to ubiquitylated 
unstable membrane proteins by a conserved ubiquitin-interacting motif (UIM) 
leading to their cleavage within TM helices or luminal domains, and 
subsequent clearance along the ERAD dislocation pathway in a p97-
dependent manner.  
Lemberg and Adrain Fig. 1
C
N
C
N
C
N
IRHD
cytosol
outside
cytosol
outside
cytosol
outside
C
N
cytosol
outside
N
cytosol
outside
C
N
cytosol
outside
UBA
C
UBA
VBM
L1 L1
L1
L1L1
Figure 1
Lemberg and Adrain Fig. 2
nucleus
NFκB
RHBDD3
endosome
C
N
IRHD
cytosol
lumen
C
N
cytosol
lumen
C
N
cytosol
lumen
C
N
cytosol
lumensignaling
scaffold
ubiquitin
de-
ubiquitylation
(B)
UBA
A20
IKKγ
TM
EM
11
5
anterograde 
trafficking
COG
C
N
IRH
D
cy
to
so
l
lu
m
en
C
N
C
N
retrograde 
trafficking
tethering
scaffold
cis-Golgi
medial-Golgi
ER
(C)
E
R
G
ol
gi Furin
regulated
trafficking
immature
ADAM17
active
ADAM17
cleaved
substrate
plasma 
membrane
iRhom2
(A)
Figure 2
Lemberg and Adrain Fig. 3
(A) (B)
Figure 3
